EPOCH PHARMACEUTICALS INC
DEL AM, 1999-10-20
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: WILD OATS MARKETS INC, S-3/A, 1999-10-20
Next: LINDNER INVESTMENTS, 497J, 1999-10-20



<PAGE>   1

                  [STRADLING YOCCA CARLSON & RAUTH LETTERHEAD]




                                October 20, 1999


United States Securities and Exchange Commission
Judiciary Plaza
450 Fifth Street N.W.
Washington, D.C. 20549

         RE:      DELAYING AMENDMENT, REGISTRATION STATEMENT ON FORM SB-2,
                  FILE NO. 333-88909, EPOCH PHARMACEUTICALS, INC.

Ladies and Gentlemen:

         In accordance with your request, the above captioned Registrant files
herewith this delaying amendment in the following form:

         THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE
OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT
SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THIS REGISTRATION
STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(A) OF
THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME
EFFECTIVE ON SUCH DATE AS THE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(A),
MAY DETERMINE.

                                                 Best regards,

                                                 STRADLING YOCCA CARLSON & RAUTH


                                                 /s/ David E. Lafitte
                                                 -------------------------------
                                                 David E. Lafitte
                                                 Attorney for
                                                 Epoch Pharmaceuticals, Inc.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission